Cargando…

C16 Peptide and Ang-1 Improve Functional Disability and Pathological Changes in an Alzheimer’s Disease Model Associated with Vascular Dysfunction

Alzheimer’s disease (AD) is a neurological disorder characterized by neuronal cell death, tau pathology, and excessive inflammatory responses. Several vascular risk factors contribute to damage of the blood–brain barrier (BBB), secondary leak-out of blood vessels, and infiltration of inflammatory ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Xiaoxiao, Wang, Jing, Cai, Huaying, Jiang, Hong, Han, Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025163/ https://www.ncbi.nlm.nih.gov/pubmed/35455468 http://dx.doi.org/10.3390/ph15040471

Ejemplares similares

C16 Peptide Promotes Vascular Growth and Reduces Inflammation in a Neuromyelitis Optica Model
por: Chen, Haohao, et al.
Publicado: (2019)

Co-Application of C16 and Ang-1 Improves the Effects of Levodopa in Parkinson Disease Treatment
por: Fu, Xiao-Xiao, et al.
Publicado: (2022)

Physiological and pathological roles of Ang II and Ang- (1-7) in the female reproductive system
por: Liu, Yuanyuan, et al.
Publicado: (2022)

TNF/Ang‐II synergy is obligate for fibroinflammatory pathology, but not for changes in cardiorenal function
por: Mayr, Magdalena, et al.
Publicado: (2016)

Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer’s disease
por: Canobbio, Ilaria, et al.
Publicado: (2015)

Michel-Ange
por: Huyghe, René

Vascular Dysfunction in Alzheimer’s Disease: A Prelude to the Pathological Process or a Consequence of It?
por: Govindpani, Karan, et al.
Publicado: (2019)

Sulfated glycans engage the Ang/Tie pathway to regulate vascular development
por: Griffin, Matthew E., et al.
Publicado: (2020)

Anges et démons
por: Brown, Dan
Publicado: (2005)

Anges et démons
Publicado: (2009)

The History of Ang. Pect.
por: Bowcock, R. L.
Publicado: (1889)

Contribution of blood platelets to vascular pathology in Alzheimer’s disease
por: Zhang, Wei, et al.
Publicado: (2013)

De Angelis : filosofía, mercado y postmodernidad /
por: Ripalda, José María
Publicado: (1996)

Gasdermin D affects aortic vascular smooth muscle cell pyroptosis and Ang II-induced vascular remodeling
por: Fang, Zimin, et al.
Publicado: (2023)

Aris Angelis (1954-2003)
Publicado: (2003)

Anges, Démons et Protons...
Publicado: (2009)

Overexpression of NOX2 Exacerbates AngII-Mediated Cardiac Dysfunction and Metabolic Remodelling
por: Hansen, Synne S., et al.
Publicado: (2022)

The promoting effect of modified Dioscorea pills on vascular remodeling in chronic cerebral hypoperfusion via the Ang/Tie signaling pathway
por: Kuang, Guiying, et al.
Publicado: (2023)

Ang1 and Ang4 differentially affect colitis and carcinogenesis in an AOM-DSS mouse model
por: Hu, Alexander, et al.
Publicado: (2023)

Combination of stromal vascular fraction and Ad-COMP-Ang1 gene therapy improves long-term therapeutic efficacy for diabetes-induced erectile dysfunction
por: Yin, Guo-Nan, et al.
Publicado: (2018)

ANG1 treatment reduces muscle pathology and prevents a decline in perfusion in DMD mice
por: Gutpell, Kelly M., et al.
Publicado: (2017)

Scoparone alleviates Ang II‐induced pathological myocardial hypertrophy in mice by inhibiting oxidative stress
por: Lyu, Linmao, et al.
Publicado: (2021)

Inhibition of Platelets by Clopidogrel Suppressed Ang II‐Induced Vascular Inflammation, Oxidative Stress, and Remodeling
por: An, Xiangbo, et al.
Publicado: (2018)

Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis
por: Ando, Kunie, et al.
Publicado: (2021)

Vascular Factors and Cognitive Dysfunction in Alzheimer Disease
por: Pachalska, Maria, et al.
Publicado: (2015)

Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis
por: Shabir, Osman, et al.
Publicado: (2018)

Vascular dysfunction and pathology: focus on mechanical forces
por: Garoffolo, Gloria, et al.
Publicado: (2021)

Ang2-Targeted Combination Therapy for Cancer Treatment
por: Liu, Na, et al.
Publicado: (2022)

Les anges de l'univers /
por: Einar Már Gudmundsson
Publicado: (1998)

ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease
por: Kuriakose, Jithin, et al.
Publicado: (2021)

Association of markers of endothelial dysregulation Ang1 and Ang2 with acute kidney injury in critically ill patients
por: Robinson-Cohen, Cassianne, et al.
Publicado: (2016)

Role of Renin-Angiotensin System Components in Atherosclerosis: Focus on Ang-II, ACE2, and Ang-1–7
por: Silva, Gabriela M., et al.
Publicado: (2020)

Le temps des anges ; Pile ou face /
por: Colomb, Catherine
Publicado: (1993)

Comparative evaluation of biased agonists Sarcosine(1), d‐Alanine (8) ‐Angiotensin (Ang) II (SD Ang II) and Sarcosine(1), Isoleucine (8) ‐Ang II (SI Ang II) and their radioiodinated congeners binding to rat liver membrane AT(1) receptors
por: Noto, Natalia M., et al.
Publicado: (2023)

The intellectual disability gene PQBP1 rescues Alzheimer’s disease pathology
por: Tanaka, Hikari, et al.
Publicado: (2018)

Anti‐VEGF‐A/ANG2 combotherapy limits pathological angiogenesis in the eye: a replication study
por: Wolf, Anne, et al.
Publicado: (2019)

Pharmacological depletion of microglia and perivascular macrophages prevents Vascular Cognitive Impairment in Ang II-induced hypertension
por: Kerkhofs, Danielle, et al.
Publicado: (2020)

Clinical and imaging features of mixed Alzheimer and vascular pathologies
por: Chui, Helena C, et al.
Publicado: (2015)

NLRP3 inflammasome activation is involved in Ang II-induced kidney damage via mitochondrial dysfunction
por: Wen, Yi, et al.
Publicado: (2016)

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
por: Wu, Moxin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qrksnceo8ul1688selu15guscp